Kiniksa inks li­cens­ing deal to take a Re­gen­eron castoff in­to Asian mar­kets

Af­ter dig­ging through Re­gen­eron’s trash bin, Kiniksa has man­aged to put to­geth­er a tiny run with the ag­ing drug Ar­c­a­lyst in re­cent years. Now, the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.